Bristol Myers Squibb CEO Chris Boerner at the Financial Times' US Pharma and Biotech Summit (Wiktoria Warpas for the Financial Times)

May 15, 2025 11:40 AM EDT

Pharma

Bristol Myers CEO says America’s biopharma pole position is not guaranteed

Max Gelman

Senior Editor

NEW YORK — Bristol Myers Squibb CEO Chris Boerner said America’s role as the global biopharma leader is at a “pivot point” as the Trump administration …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Bristol Myers CEO says America’s biopharma pole position is not guaranteed

Max Gelman

Senior Editor

Sign up to read this article for free.

COO / Head of Operations (Stealth Portfolio Company)‬ ‭

Autonomy Bio Inc.

San Francisco, CA 94107, USA

The inside story of the six-month sprint to create the first custom CRISPR therapy for one infant’s rare disease

Exclusive: Drug compounder Empower was built on risky shortcuts, ex-employees and inspections allege

Biohaven stock sinks on three-month delay for neuro drug's FDA approval decision

New CBER chief Prasad is readying 'massive framework' around vaccines, Makary says

Pathos AI collects $365M to fuel 'bulletproof' oncology trials and in-license more cancer drugs

Eli Lilly turns to South Korean RNA editing biotech for hearing loss in deal worth $1.3B

Bris­tol My­ers CEO says Amer­i­ca’s bio­phar­ma pole po­si­tion is not guar­an­teed

Senior Editor

Sign up to read this article for free.

more like this

Autonomy Bio Inc.

San Francisco, CA 94107, USA

Bristol Myers CEO says America’s biopharma pole position is not guaranteed